glp 1 agonist lilly Eli Lilly's orforglipron: a new oral GLP-1 therapy | Thomas Fessard posted on the topic Eli Lilly's Obesity Pill Appears

(One quick note: These numbers are actually much lower than other estimates Ive seen

Cancer incidence and mortality in relation to body mass index in the million women study: cohort study

Mol Hum Reprod (2017) 23(10):698707

Lower blood pressure and BW loss correlate independently with SGLT2 inhibitor treatment, with the effect of both GLP-1RA and SGLT2 inhibitors being significantly greater on systolic BP than on diastolic BP [4]

Persistent fatigue warrants evaluation for undereating, sleep deprivation, thyroid dysfunction, or anemianone of which are direct tirzepatide effects

Recuperato da: Cooper J, Donovan K, Michel H, Peterson L, Todd-Thompson M, Gillette C, et al